{
  "url": "https://openlegislation.uk/human-medicines-amendment-regulations-2019/regulation-19",
  "json_url": "https://openlegislation.uk/human-medicines-amendment-regulations-2019/regulation-19.json",
  "legislation": "uksi/2019/62",
  "legislation_title": "The Human Medicines (Amendment) Regulations 2019",
  "legislation_url": "https://openlegislation.uk/human-medicines-amendment-regulations-2019",
  "path": "regulation/19",
  "kind": "regulation",
  "number": "19",
  "heading": "Amendment of Schedule 24 (packaging information requirements)",
  "text": "In schedule 24, after paragraph 18 insert—\n“18A. In the case of a medicinal product, other than a radiopharmaceutical, that is required by Article 54a of the 2001 Directive to bear safety features—\n(a) a unique identifier which complies with the technical specifications set out in Chapter II of Commission Regulation 2016/161; and\n(b) an anti-tampering device allowing verification of whether the packaging of the medicinal product has been tampered with.”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2019/62/regulation/19",
    "retrieved_at": "2026-10-28T22:49:09.308987+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}